Evidence map›Paper›PMID 40495482›Full record

ArticleBMB reports2025

mTORC1 and STAT3 signaling are indispensable for in vitro TGFβ1-dependent three-dimensional (3D) tendon constructs.

Bon-Hyeock Koo, Aiden Smith, Kyu Sang Joeng

Abstract read
In one paragraph

Article in BMB reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bon-Hyeock KooMcKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6081, USA.
Aiden SmithMcKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6081, USA.
Kyu Sang JoengMcKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6081, USA.

Funding

Overall: Resource-based Center for Musculoskeletal Disorders Research (Overall Application)P30AR069619 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI LOUIS J SOSLOWSKY · 2016 to 2026
$9.1M
The function of mTORC1/Stat3 signaling in the regulation of fibrovascular scar formation during tendon healingR01AR079486 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Nathaniel A. Dyment · 2022 to 2026
$1.7M
NIAMS NIH HHS P30 AR069619NIAMS NIH HHS R01 AR079486
6 · The paper itself

Abstract

Transforming Growth Factor-β1 (TGFβ1) is an established growth factor that regulates tenocyte differentiation, extracellular matrix production, and cell fate. We previously demonstrated its pivotal role in in vitro 3D tendon constructs formation; however, the downstream signaling mechanisms remain elusive. In this study, we explore the roles of mTORC1 (Mammalian Target of Rapamycin Complex 1) and STAT3 (Signal Transducer and Activator of Transcription 3) in mediating TGFβ1-induced 3D tendon formation using rapamycin (an mTORC1 inhibitor) and stattic (a STAT3 inhibitor). Inhibition of either pathway compromised TGFβ1-induced thickening of the tendon construct, cellular proliferation, and collagen fibrillogenesis. Molecular analyses revealed that mTORC1-STAT3 signaling partially mediates TGFβ1-induced Scx expression and tenocyte elongation in the peripheral layer of 3D tendon constructs. Moreover, TGFβ1 treatment augmented mTOR and STAT3 phosphorylation, while inhibition of mTORC1 signaling attenuated TGFβ1-induced STAT3 phosphorylation. These findings underscore the TGFb1-mTORC1-STAT3 signaling pathway as integral to 3D tendon constructs. Overall, our study identifies the mTORC1-STAT3 axis as a crucial mediator of TGFβ1-driven in vitro tendon formation, highlighting its importance in tendon maturation and extracellular matrix organization. [BMB Reports 2025; 58(6): 257-263].

Indexed as

Mechanistic Target of Rapamycin Complex 1STAT3 Transcription FactorTendonsTransforming Growth Factor beta1AnimalsCell DifferentiationCell ProliferationCells, CulturedExtracellular MatrixPhosphorylationSignal TransductionSirolimusTenocytesMechanistic Target of Rapamycin Complex 1SirolimusSTAT3 Transcription FactorTransforming Growth Factor beta1

Identifiers

PMID40495482
PMCPMC12207444

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.